000			01340 a2200373 4500
005			20250511171103.0
264		0	_c19751122
008			197511s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm00242a019 _2doi
040			_aNLM _beng _cNLM
100	1		_aPeng, G W
245	0	0	_aPotential central nervous system antitumor agents. Hydantoin derivatives. _h[electronic resource]
260			_bJournal of medicinal chemistry _cAug 1975
300			_a846-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xchemical synthesis
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCentral Nervous System
650	0	4	_aEpendymoma _xdrug therapy
650	0	4	_aHydantoins _xchemical synthesis
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aLeukemia L1210 _xdrug therapy
650	0	4	_aLeukemia, Experimental _xdrug therapy
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMice
650	0	4	_aNeoplasms, Experimental _xdrug therapy
650	0	4	_aNitrogen Mustard Compounds _xchemical synthesis
700	1		_aMarquez, V E
700	1		_aDriscoll, J S
773	0		_tJournal of medicinal chemistry _gvol. 18 _gno. 8 _gp. 846-9
856	4	0	_uhttps://doi.org/10.1021/jm00242a019 _zAvailable from publisher's website
999			_c1166378 _d1166378